Think Bioscience
Pre-clinicalThink Bioscience engineers microbes to produce sustainable chemicals and pharmaceuticals using synthetic biology.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $57M
About
Think Bioscience engineers microbes to produce sustainable chemicals and pharmaceuticals using synthetic biology.
Synthetic BiologyMetabolic
Funding History
2Total raised:$57M
Series A$47MMay 15, 2023
Seed$10MOct 15, 2021